Carlos A Scrideli
Scrideli C, Assumpção J, Ganazza M, Araújo M, Toledo S, Lee M, et al
. A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica. 2009;94:781-9 pubmed publisher
Darrigo Júnior L, Lira R, Fedatto P, Marco Antonio D, Valera E, Aguiar S, et al
. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. J Neurooncol. 2018;: pubmed publisher
..In summary, our data demonstrate that PA harbors at least two distinct miRNA signatures, including a subgroup of patients with NF1/PA lesions. ..
Baroni M, Marie S, Fedatto P, Andrade A, Suazo V, Cruzeiro G, et al
. Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines. J Neurooncol. 2018;139:51-60 pubmed publisher
..These results demonstrated that GBM cell lines had distinct responses to GDF15 knockdown, a fact that can be explained by the different molecular profile of pediatric and adult GBM. ..
Sales L, Pezuk J, Borges K, Brassesco M, Scrideli C, Tone L, et al
. Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma. BMC Complement Altern Med. 2015;15:393 pubmed publisher
..The present study demonstrates for the first time the anticancer potential of 7-epiclusianone against glioblastoma cells, thus meriting its further investigation as a potential therapeutic agent. ..
Peixoto Lira R, Fedatto P, Marco Antonio D, Leal L, Martinelli C, de Castro M, et al
. IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis. Endocr Relat Cancer. 2016;23:481-93 pubmed publisher
..However, in vitro treatments with high concentrations of OSI-906 (>1Î¼M) showed limited reduction of cell viability, suggesting that OSI-906 alone could not be a suitable therapy to abolish carcinoma cell growth. ..
Scrideli C, Cortez M, Yunes J, Queiroz R, Valera E, da Mata J, et al
. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leuk Res. 2010;34:32-7 pubmed publisher
..04) and multivariable analysis (P=0.01). Our data address new information in the complex interaction of the migration/adhesion genes and childhood ALL. ..